Cargando…

Neoantigens as potential vaccines in hepatocellular carcinoma

BACKGROUND: Neoantigens, new immunogenic sequences arising from tumor mutations, have been associated with response to immunotherapy and are considered potential targets for vaccination. Hepatocellular carcinoma (HCC) is a moderately mutated tumor, where the neoantigen repertoire has not been invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Repáraz, David, Ruiz, Marta, Llopiz, Diana, Silva, Leyre, Vercher, Enric, Aparicio, Belén, Egea, Josune, Tamayo-Uria, Ibon, Hervás-Stubbs, Sandra, García-Balduz, Jorge, Castro, Carla, Iñarrairaegui, Mercedes, Tagliamonte, Maria, Mauriello, Angela, Cavalluzzo, Beatrice, Buonaguro, Luigi, Rohrer, Charlotte, Heim, Kathrin, Tauber, Catrin, Hofmann, Maike, Thimme, Robert, Sangro, Bruno, Sarobe, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066373/ https://www.ncbi.nlm.nih.gov/pubmed/35193931 http://dx.doi.org/10.1136/jitc-2021-003978

Ejemplares similares

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
por: Repáraz, David, et al.
Publicado: (2022)

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma
por: Silva, Leyre, et al.
Publicado: (2020)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)

Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023)

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
por: Petrizzo, Annacarmen, et al.
Publicado: (2021)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
por: Petrizzo, Annacarmen, et al.
Publicado: (2018)

Inflammation and immunity in ovarian cancer
por: Salas-Benito, Diego, et al.
Publicado: (2020)

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
por: Llopiz, Diana, et al.
Publicado: (2018)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
por: Zabaleta, Aintzane, et al.
Publicado: (2015)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
por: Ragone, Concetta, et al.
Publicado: (2021)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
por: Manolio, Carmen, et al.
Publicado: (2022)

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy
por: Mauriello, Angela, et al.
Publicado: (2020)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination
por: Llopiz, Diana, et al.
Publicado: (2016)

Advances in immunotherapy for hepatocellular carcinoma
por: Sangro, Bruno, et al.
Publicado: (2021)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
por: Aparicio, Belén, et al.
Publicado: (2021)

Methodological approaches to the study of cancer risk in the vicinity of pollution sources: the experience of a population-based case–control study of childhood cancer
por: García-Pérez, Javier, et al.
Publicado: (2019)

Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib
por: Sangro, Bruno, et al.
Publicado: (2012)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
por: Tagliamonte, Maria, et al.
Publicado: (2022)

Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Corrigendum: Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
por: Chandran, Smita S., et al.
Publicado: (2022)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
por: Tagliamonte, M, et al.
Publicado: (2009)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Pneumatocele during sorafenib therapy: first report of an unusual complication
por: Sangro, Paloma, et al.
Publicado: (2017)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
por: Lozano, Teresa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kuq6451ojr45kltpk8fp0ak4be